Cynata Therapeutics Limited (FRA:51S)

Cynata Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	5.05	6.21	16.17	23.8	26.72
Cash & Short-Term Investments	5.05	6.21	16.17	23.8	26.72
Cash Growth	-18.62%	-61.62%	-32.06%	-10.92%	95.73%
Other Receivables	0.1	0.11	0.34	0.07	0.04
Receivables	0.1	0.11	0.34	0.07	0.25
Prepaid Expenses	0.19	0.22	0.33	0.24	0.29
Other Current Assets	0	0	0.03	0.03	0.03
Total Current Assets	5.35	6.54	16.86	24.14	27.28
Long-Term Deferred Charges	1.85	1.85	2.13	2.41	2.69
Total Assets	7.2	8.39	18.99	26.55	29.97
Accounts Payable	0.39	0.43	1.31	1.58	0.68
Accrued Expenses	0.82	0.74	0.95	1.01	0.93
Total Current Liabilities	1.22	1.17	2.26	2.59	1.6
Total Liabilities	1.22	1.17	2.26	2.59	1.6
Common Stock	89.52	81.62	81.62	74.9	74.9
Retained Earnings	-91.71	-82.32	-72.57	-58.3	-52.85
Comprehensive Income & Other	8.17	7.91	7.68	7.36	6.32
Shareholders' Equity	5.98	7.22	16.73	23.96	28.37
Total Liabilities & Equity	7.2	8.39	18.99	26.55	29.97
Net Cash (Debt)	5.05	6.21	16.17	23.8	26.72
Net Cash Growth	-18.62%	-61.62%	-32.06%	-10.92%	95.73%
Net Cash Per Share	0.02	0.03	0.11	0.17	0.20
Filing Date Shares Outstanding	237.45	180.55	179.63	143.28	143.28
Total Common Shares Outstanding	225.95	179.63	179.63	143.28	143.28
Working Capital	4.13	5.37	14.6	21.55	25.68
Book Value Per Share	0.03	0.04	0.09	0.17	0.20
Tangible Book Value	5.98	7.22	16.73	23.96	28.37
Tangible Book Value Per Share	0.03	0.04	0.09	0.17	0.20

Source: S&P Global Market Intelligence. Standard template. Financial Sources.